Physician profile
Amy Gordon
NPI 1629062922
$7,215.11
in general payments reported to CMS, 2019-2025
35 companies · $693 in 2025
The $693 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $107 · 2021: $3,760 · 2022: $733 · 2023: $966 · 2024: $640 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,114.89 |
| Education | $184.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,161.16 | 2021 | |
| Mayne Pharma Commercial LLC | $667.00 | 2021-2025 | |
| Astellas Pharma US INC | $552.47 | 2023-2025 | Veozah |
| Abbvie INC. | $431.41 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $349.47 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $258.82 | 2019-2025 | |
| Pfizer INC. | $241.85 | 2019-2023 | |
| Biogen, INC. | $171.93 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $126.65 | 2020-2022 | |
| Hologic Sales and Service, LLC | $125.72 | 2019-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Organon LLC | $125.36 | 2021-2025 | Nexplanon, Jada System |
| Cook Medical LLC | $110.12 | 2023 | Cook |
| Exeltis, USA INC. | $94.90 | 2021-2025 | Slynd |
| Shield Therapeutics INC | $87.06 | 2023-2025 | Accrufer |
| Agiliti Surgical, INC. | $81.29 | 2025 | Boston Scientific Acupulse Duo Co2 Laser, Ge Healthcare Bk3000/Bk5000 Ultrasound |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $76.92 | 2021-2022 | |
| Smith+Nephew, INC. | $58.19 | 2020-2021 | |
| Evofem Biosciences, INC. | $48.30 | 2021 | |
| Mylan Pharmaceuticals INC. | $47.45 | 2019-2020 | |
| Aspira Women'S Health INC | $46.20 | 2022 | |
| Conmed Corporation | $43.87 | 2025 | Airseal |
| Agile Therapeutics, INC. | $39.48 | 2021-2022 | |
| Applied Medical Resources Corporation | $36.08 | 2023 | |
| Merck Sharp & Dohme LLC | $31.86 | 2019-2021 | |
| Avion Pharmaceuticals | $30.90 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.88 | 2019 | |
| Becton, Dickinson and Company | $24.44 | 2019 | |
| Allergan, INC. | $22.18 | 2019-2020 | |
| Millicent US INC | $21.57 | 2025 | Intrarosa, Femlyv |
| Meditrina | $19.36 | 2021 | |
| Solventum Corporation | $13.93 | 2025 | Prevena |
| Lupin INC. | $13.68 | 2020 | |
| Bard Access Systems, INC. | $12.48 | 2019 | |
| Gilead Sciences, INC. | $12.35 | 2022 | |
| Kinex Medical Company LLC | $4.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.